IMARC Group has recently released a new research study titled “Artificial Pancreas Device Systems (APDS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
How big is the artificial pancreas device systems market?
The global artificial pancreas device systems market size reached US$ 2,208.2 Million in 2022. Looking forward, IMARC Group expects the APDS market to reach US$ 4,500.6 Million by 2028, exhibiting a growth rate (CAGR) of 11.8% during 2023-2028.
What is artificial pancreas device systems?
An artificial pancreas device system (APDS) represents a closed-loop or automated insulin delivery system that manages blood glucose levels by regulating the production of insulin. It consists of a continuous glucose monitor (CGM), a subcutaneous insulin infusion pump, and a controller that links the monitor with the pump. The artificial pancreas device system runs a complex algorithm that determines the adequate levels of insulin and time of delivery based on the evaluation of real-time glucose readings. As such, it is commonly utilized to minimize the risks of extreme fluctuations of glucose levels in the body.
Request to get the sample report: https://www.imarcgroup.com/artificial-pancreas-device-systems-market/requestsample
What are the growth prospects and trends in the artificial pancreas device system industry?
The rising prevalence of pancreatic cancer, pancreatitis, and other chronic ailments is among the key factors stimulating the artificial pancreas device systems (APDS) market. Moreover, the growing occurrence of obesity and diabetes, owing to physical inactivity and unhealthy dietary patterns of individuals, is positively influencing the global market.
Besides this, the escalating demand for minimally invasive (MI) drug delivery systems is propelling the market growth. Furthermore, numerous technological innovations, including the development of software-based wireless systems that are integrated with automated controls, are also bolstering the global market.
Apart from this, the increasing investments by government bodies across several countries in R&D activities for improving healthcare infrastructures are acting as significant growth-inducing factors. Additionally, the introduction of advanced devices that use artificial intelligence (AI) and machine learning to understand the changing insulin needs of the patient is anticipated to fuel the artificial pancreas device systems (APDS) market over the forecasted period.
Who are the key manufactures operating in the industry?
The report covers the major market players including:
Artificial Pancreas Device Systems Manufacturers:
- Beta Bionics Inc.
- Bigfoot Biomedical Inc.
- Dexcom Inc.
- Inreda Diabetic B.V.
- Insulet Corporation
- Johnson & Johnson
- Medtronic Inc.
- Roche Holding AG
- Tandem Diabetes Care Inc.
Key Market Segmentation:
The report has segmented the global artificial pancreas device systems market on the basis of device type, treatment type, end-user and region.
Breakup by Device Type:
- Threshold Suspend Device Systems
- Control- to-Range Systems
- Control-to-Target Systems
Breakup by Treatment Type:
- Bi-hormonal
- Insulin Only
- Hybrid
Breakup by End-User:
- Hospital
- Medical Centers
- Others
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Explore Full Report Description At: https://www.imarcgroup.com/artificial-pancreas-device-systems-market
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
Read Newsletter: https://www.linkedin.com/newsletters/industry-news-about-6929400456628637696
